{"transactions":[{"id":1387115,"issuer":{"id":9689,"kind":"organization","name":"AXIM BIOTECHNOLOGIES, INC."},"owners":[{"id":86797,"kind":"person","name":"Valencia Catalina","position":1,"cik":"0001944813","reported_name":"Valencia Catalina","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and Director"}}],"security":"Common Stock","published_at":"2024-10-15T17:05:08.000Z","date":"2024-01-30","kind":"purchase","planned":false,"acquired":true,"shares":1086216,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Acquired from third party"}],"balance_after":28608220,"source":{"system":"sec-edgar","filing":"0001096906-24-002004","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1944813/000109690624002004/form4.xml","form_type":"4"}},{"id":1570578,"issuer":{"id":9689,"kind":"organization","name":"AXIM BIOTECHNOLOGIES, INC."},"owners":[{"id":86797,"kind":"person","name":"Valencia Catalina","position":1,"cik":"0001944813","reported_name":"Valencia Catalina","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Convertible Note","published_at":"2024-03-19T19:39:54.000Z","date":"2024-03-15","kind":"grant","planned":false,"acquired":true,"shares":7837500,"price":156750,"value":1228528125000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reporting Person acquired a convertible note, face value $156,750.  The note is convertible into shares of the Issuer's common stock at a price of $0.02 per share for conversion into a total of 7,837,500 shares.."}],"balance_after":7837500,"derivative":{"exercise_price":0.02,"exercise_date":"2024-03-15","expiration_date":"2034-03-01","underlying":"Common Stock","underlying_shares":7837500},"source":{"system":"sec-edgar","filing":"0001096906-24-000524","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1944813/000109690624000524/form4.xml","form_type":"4"}},{"id":2170254,"issuer":{"id":9689,"kind":"organization","name":"AXIM BIOTECHNOLOGIES, INC."},"owners":[{"id":86797,"kind":"person","name":"Valencia Catalina","position":1,"cik":"0001944813","reported_name":"Valencia Catalina","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-31T16:01:16.000Z","date":"2022-08-24","kind":"purchase","acquired":true,"shares":3861004,"price":0.0259,"value":100000.0036,"ownership":{"direct":true},"balance_after":23661004,"source":{"system":"sec-edgar","filing":"0001096906-22-002075","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1944813/000109690622002075/form4.xml","form_type":"4"}}]}